UNSPSC 51432108: Pinacidil

This classification denotes an antihypertensive agent with the molecular formula C13H19N5.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7B0ZZH8P2W, chemically known as 2-cyano-3-(4-pyridinyl)-1-(1,2,2-trimethylpropyl)guanidine but generally known as pinacidil, which bears US NIH Compound Identifier 4826. European Medicines Agency schedules Pinacidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09848MIG.

UNSPSC 51432108 Pinacidil, a Commodity code, represents medications and pharmaceutical products that state and local governments procure for emergency medical services, public health programs, and cooperative purchasing agreements across multiple jurisdictions. State and local buyers under this code acquire specific Advanced Life Support medications, generic pharmaceuticals, and over-the-counter products through sealed bids, RFPs, and cooperative purchasing vehicles. Issuing bodies include municipal fire and rescue departments, state health and human services agencies, and multistate cooperative purchasing alliances that aggregate demand across participating state and local facilities. The procurement typically requires vendors to maintain minimum shelf life and expiration standards (nine months to one year from delivery or manufacture), comply with FDA requirements and cGMP certifications, supply products through authorized wholesaler networks, provide comprehensive safety documentation including Safety Data Sheets and accessibility conformance reports, and arrange rapid delivery—often within ten calendar days of order receipt. Many jurisdictions apply small and local business enterprise set-asides or bid preferences to encourage participation by certified disadvantaged vendors.

Recent activity spans Florida, Texas, and Minnesota-led multistate purchasing. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications (Epinephrine, Labetalol, Adenosine, Diltiazem) for Tampa Fire Rescue with a due date of April 8, 2026 and an estimated contract value of $40,000, including a 5 percent SLBE bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 in March 2026 to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program outside traditional PBM and wholesaler arrangements, reflecting state interest in alternative pharmacy benefit delivery models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with proposals due March 26, 2026 and contract effectiveness July 1, 2026, covering participating state and local facilities in Minnesota, Oregon, and other MMCAP member jurisdictions. Vendors on these cooperative contracts typically pay 3 percent administrative fees and must maintain insurance coverage of $5 million general liability and $2 million network security coverage.